Search Results 4151-4160 of 16154 for brca1%20and%20brca2%20genes%20and%20breast%20cancer

  1. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  2. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

    ... (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The ... * Documented germline or somatic mutation in BRCA1, BRCA2, or germline ...

  3. Niraparib + TSR042 In BRCA Mutated Breast Cancer - Mayo Clinic

    The purpose of this study is to evaluate pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA mutations. The drugs are ...

  4. Clinical trials - Oncology (Medical)

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

  5. Clinical trials - Oncology (Medical)

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

  6. Clinical trials - Oncology (Medical)

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

  7. Clinical trials - Oncology (Medical)

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

  8. Clinical trials - Oncology (Medical)

    This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

  9. Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy Or Plus Camizestrant In HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer - Mayo Clinic

    ... BRCA1, BRCA2, Or PALB2m Advanced Breast Cancer. Print details. Share; Facebook ... BRCA1, BRCA2, or PALB2m, HR-positive, HER2-negative (defined as IHC 0 ...

  10. Clinical trials - Oncology (Medical)

    Patients with BRCA mutations are not excluded from this trial and are allowed to receive standard of care maintenance therapy including bevacizumab and/or PARP ...